tuftsin has been researched along with Disease Models, Animal in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (9.52) | 18.7374 |
| 1990's | 1 (4.76) | 18.2507 |
| 2000's | 6 (28.57) | 29.6817 |
| 2010's | 11 (52.38) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, Y; Huang, W; Li, F; Li, S; Niu, H; Wan, C; Wang, Y; Wei, Z; Wen, E; Xin, G; Yu, X; Zhang, K; Zhu, Y | 1 |
| Bao, Z; Feng, F; Hao, J; Li, Y | 1 |
| Barshack, I; Bashi, T; Ben-Ami-Shor, D; Blank, M; Eisenstein, M; Fridkin, M; Lachnish, J; Shoenfeld, Y; Shovman, O; Volkov, A | 1 |
| Nissen, JC; Pretory, A; Thompson, KK; Tsirka, SE | 1 |
| Blank, M; Shoenfeld, Y | 1 |
| Barshak, I; Bashi, T; Ben-Ami Shor, D; Bizzaro, G; Blank, M; Fridkin, M; Lachnish, J; Shoenfeld, Y | 1 |
| Barshak, I; Bashi, T; Ben-Ami Shor, D; Blank, M; Fridkin, M; Gendelman, O; Shoenfeld, Y; Versini, M; Volkov, A | 1 |
| Chai, YF; Dong, N; Gao, YL; Han, S; Yao, YM; Zhang, QH; Zhu, XM | 1 |
| Nissen, JC; Tsirka, SE | 1 |
| Chai, YF; Gao, YL; Liu, YC; Lu, B; Shou, ST; Wang, LJ; Yao, Y; Yu, MM | 1 |
| Fu, G; Hua, Y; Keep, RF; Song, S; Wu, J; Xi, G; Yang, S | 1 |
| Burenchev, DV; Dubina, AI; Gubskiĭ, LV; Povarova, OV; Skvortsova, VI; Stakhovskaia, LV; Tvorogova, TV | 1 |
| Aljarbou, A; Khan, A; Khan, MA; Owais, M | 1 |
| Bo, H; Chen, A; Guo, J; Han, S; Liu, X; Xu, P; Yang, Q; Yao, L; Yin, J; Zhang, Z | 1 |
| Rogove, AD; Tsirka, AE; Tsirka, SE; Wang, J | 1 |
| Faisal, SM; Khan, MA; Mohammad, O | 1 |
| Bhasin, M; Tsirka, SE; Wu, M | 1 |
| Baker, CC; Gaines, HO; Niven-Fairchild, AT | 1 |
| Acs, G; Furka, I; Hajdu, Z; Kathy, S; Mikó, I; Szabó, L; Szendrói, T | 1 |
| Faisal, SM; Haque, W; Masood, AK; Owais, M | 1 |
| Smith, PC; Stern, GA; Zam, ZS | 1 |
1 review(s) available for tuftsin and Disease Models, Animal
| Article | Year |
|---|---|
Helminth-Related Tuftsin-Phosphorylcholine Compound and its Interplay with Autoimmune Diseases.
Topics: Animals; Autoimmune Diseases; Disease Models, Animal; Helminthiasis; Helminths; Humans; Immunologic Factors; Immunomodulation; Mice; Phosphorylcholine; Tuftsin | 2019 |
20 other study(ies) available for tuftsin and Disease Models, Animal
| Article | Year |
|---|---|
Tuftsin ameliorates splenic inflammatory injury by promoting neuropilin-1 in severe acute pancreatitis.
Topics: Acute Disease; Animals; Disease Models, Animal; Inflammation; Neuropilin-1; Pancreatitis; Spleen; Tuftsin | 2022 |
Promotion of microglial phagocytosis by tuftsin stimulates remyelination in experimental autoimmune encephalomyelitis.
Topics: Animals; Calcium-Binding Proteins; Central Nervous System Stimulants; Cytokines; Disease Models, Animal; Encephalomyelitis; Encephalomyelitis, Autoimmune, Experimental; Female; Mice; Mice, Inbred C57BL; Microfilament Proteins; Microglia; Multiple Sclerosis; Myelin Sheath; Oligodendroglia; Phagocytosis; Remyelination; Tuftsin | 2019 |
Helminths-based bi-functional molecule, tuftsin-phosphorylcholine (TPC), ameliorates an established murine arthritis.
Topics: Animals; Arthritis, Experimental; B-Lymphocytes; Disease Models, Animal; HEK293 Cells; Helminths; Humans; Interleukin-10; Interleukin-1beta; Joints; Macrophages; Male; Mice; Mice, Inbred DBA; Neuropilin-1; NF-kappa B; Phosphorylcholine; T-Lymphocytes, Regulatory; Toll-Like Receptor 4; Tuftsin | 2018 |
Tuftsin Combines With Remyelinating Therapy and Improves Outcomes in Models of CNS Demyelinating Disease.
Topics: Animals; Benztropine; Cuprizone; Disease Models, Animal; Drug Therapy, Combination; Encephalomyelitis, Autoimmune, Experimental; Mice; Multiple Sclerosis; Myelin Sheath; Tuftsin | 2018 |
Phosphorylcholine-tuftsin compound prevents development of dextransulfate-sodium-salt induced murine colitis: implications for the treatment of human inflammatory bowel disease.
Topics: Animals; Colitis; Cytokines; Dextran Sulfate; Disease Models, Animal; Humans; Immunologic Factors; Inflammatory Bowel Diseases; Intestinal Mucosa; Male; Mice; Phosphorylcholine; Severity of Illness Index; Tuftsin | 2015 |
Successful modulation of murine lupus nephritis with tuftsin-phosphorylcholine.
Topics: Animals; Autoantibodies; Cytokines; Disease Models, Animal; Forkhead Transcription Factors; Glomerular Mesangium; Glomerulonephritis; Humans; Injections, Subcutaneous; Interleukin-2 Receptor alpha Subunit; Lupus Erythematosus, Systemic; Lupus Nephritis; Lymphocyte Activation; Mice; Mice, Inbred NZB; Phosphorylcholine; T-Lymphocytes, Regulatory; Tuftsin | 2015 |
Tuftsin-derived T-peptide prevents cellular immunosuppression and improves survival rate in septic mice.
Topics: Animals; Antigens, Surface; Apoptosis; CTLA-4 Antigen; Cytokines; Disease Models, Animal; Forkhead Transcription Factors; Gene Expression; Immunity, Cellular; Immunologic Factors; Immunomodulation; Immunophenotyping; Interleukin-2; Lymphocyte Activation; Mice; Phenotype; Sepsis; T-Lymphocyte Subsets; Transforming Growth Factor beta; Tuftsin | 2015 |
Tuftsin-driven experimental autoimmune encephalomyelitis recovery requires neuropilin-1.
Topics: Animals; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Immunologic Factors; Macrophage Activation; Mice, Transgenic; Microglia; Multiple Sclerosis; Neuropilin-1; T-Lymphocytes; Tuftsin | 2016 |
Tuftsin prevents the negative immunoregulation of neuropilin-1highCD4+CD25+Regulatory T cells and improves survival rate in septic mice.
Topics: Animals; Cells, Cultured; CTLA-4 Antigen; Disease Models, Animal; DNA Methylation; Dose-Response Relationship, Drug; Forkhead Transcription Factors; Immunologic Factors; Interleukin-2 Receptor alpha Subunit; Male; Mice, Inbred BALB C; Neuropilin-1; Sepsis; Signal Transduction; T-Lymphocytes, Regulatory; Time Factors; Transforming Growth Factor beta; Tuftsin | 2016 |
Microglial activation and brain injury after intracerebral hemorrhage.
Topics: Animals; Animals, Newborn; Brain Edema; Brain Injuries; CD11b Antigen; Cells, Cultured; Cerebral Cortex; Cerebral Hemorrhage; Disease Models, Animal; Immunologic Factors; Interleukin-1beta; Ions; Male; Microglia; Rats; Rats, Sprague-Dawley; Thrombin; Time Factors; Tuftsin; Tumor Necrosis Factor-alpha; Up-Regulation | 2008 |
[Experimental hemorrhagic stroke: the study of neuropeptides (MIF, selank) in the intraperitoneal injection].
Topics: Animals; Body Weight; Disease Models, Animal; Injections, Intraperitoneal; Macrophage Migration-Inhibitory Factors; Magnetic Resonance Imaging; Oligopeptides; Rats; Stroke; Tuftsin | 2009 |
Immune stimulating and therapeutic potential of tuftsin-incorporated nystatin liposomes against Cryptococcus neoformans in leukopenic BALB/C mice.
Topics: Animals; Antifungal Agents; Brain; Cells, Cultured; Cryptococcosis; Cryptococcus neoformans; Disease Models, Animal; Immunologic Factors; Liposomes; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Nystatin; Survival Analysis; Treatment Outcome; Tuftsin | 2012 |
Enhanced immune response induced by a potential influenza A vaccine based on branched M2e polypeptides linked to tuftsin.
Topics: Animals; Antibodies, Viral; Antigens, Viral; Disease Models, Animal; Female; Influenza Vaccines; Leukocytes, Mononuclear; Mice; Mice, Inbred BALB C; Orthomyxoviridae Infections; Survival Analysis; Tuftsin; Viral Matrix Proteins | 2012 |
Protective role of tuftsin fragment 1-3 in an animal model of intracerebral hemorrhage.
Topics: Animals; Brain; Cerebral Hemorrhage; Collagenases; Disease Models, Animal; Fluorescent Antibody Technique; Injections, Intraventricular; Matrix Metalloproteinases; Mice; Microglia; Tissue Plasminogen Activator; Tuftsin | 2003 |
Safety, efficacy and pharmacokinetics of tuftsin-loaded nystatin liposomes in murine model.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Humans; Immunologic Factors; Liposomes; Male; Mice; Microbial Sensitivity Tests; Nystatin; Treatment Outcome; Tuftsin | 2006 |
Modulation of microglial/macrophage activation by macrophage inhibitory factor (TKP) or tuftsin (TKPR) attenuates the disease course of experimental autoimmune encephalomyelitis.
Topics: Animals; Cell Proliferation; Disease Models, Animal; Disease Progression; Encephalomyelitis, Autoimmune, Experimental; Female; Immunization; Immunologic Factors; Macrophage Activation; Macrophage Migration-Inhibitory Factors; Macrophages; Mice; Mice, Knockout; Mice, Transgenic; Microglia; Myelin Proteins; Myelin Sheath; Myelin-Associated Glycoprotein; Myelin-Oligodendrocyte Glycoprotein; Th1 Cells; Th2 Cells; Tissue Plasminogen Activator; Tuftsin | 2007 |
The effect of tuftsin and splenectomy on mortality after intraabdominal sepsis.
Topics: Abdomen; Animals; Bacterial Infections; Cecum; Disease Models, Animal; Ligation; Male; Mice; Mice, Inbred CBA; Splenectomy; Therapeutic Irrigation; Tuftsin | 1984 |
Splenic autotransplantation after abdominal trauma in childhood. Clinical and experimental data.
Topics: Abdominal Injuries; Animals; Antibody Formation; Bacterial Infections; Blood Cell Count; Child; Disease Models, Animal; Dogs; Female; Follow-Up Studies; Humans; Immunoglobulin M; Iron; Leukocyte Count; Lymphopenia; Male; Omentum; Platelet Count; Radionuclide Imaging; Risk Factors; Spleen; Splenectomy; T-Lymphocytes; Transplantation, Autologous; Tuftsin | 1997 |
Immunomodulator tuftsin augments anti-fungal activity of amphotericin B against experimental murine candidiasis.
Topics: Adjuvants, Immunologic; Amphotericin B; Animals; Antifungal Agents; Antigens; Candida albicans; Candidiasis; Disease Models, Animal; Drug Resistance, Fungal; Drug Synergism; Female; Immunoglobulin G; Kidney; Liposomes; Liver; Lung; Mice; Mice, Inbred BALB C; Ovalbumin; Spleen; T-Lymphocytes; Tuftsin | 2002 |
The effect of tuftsin in the treatment of experimental Pseudomonas keratitis.
Topics: Animals; Colony Count, Microbial; Disease Models, Animal; Drug Combinations; Eye Infections, Bacterial; Female; Gentamicins; Keratitis; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Tuftsin | 1986 |